Sunshine Biopharma Inc. (SBFMW) Gross profit 2017–2025
Sunshine Biopharma Inc. (SBFMW) annual gross profit history from SEC filings — each fiscal year as reported.
$12.3MFY2025 · since FY2017: $0 → $12.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $12.3M | +14.9% |
| FY2024 | $10.7M | +27.9% |
| FY2023 | $8.3M | +391.5% |
| FY2022 | $1.7M | +1434.0% |
| FY2021 | $110,596 | +142.7% |
| FY2020 | $45,563 | +352.4% |
| FY2019 | $10,071 | — |
| FY2018 | $0 | — |
| FY2017 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SBFMW financial trends
SBFMW RevenueSBFMW Net incomeSBFMW Net marginSBFMW Gross marginSBFMW Operating incomeSBFMW Operating marginSBFMW Operating cash flowSBFMW Free cash flowSBFMW Capital expendituresSBFMW Return on equitySBFMW Stock buybacksSBFMW Dividends paidSBFMW Total assetsSBFMW Total liabilitiesSBFMW Shareholders’ equitySBFMW overview →